Perspective: Advances on hypoxia inducible factor-1

Chinese Medical Journal

Volumn 126, Issue 18, 2013, Pages 3567-3571

  Wang, Xiao Jun ^a   Si, Lou Bin ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Angiogenesis; Biological characteristic; Hypoxia; Hypoxia inducible factor 1; Tumor

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ANGIOPOIETIN 1; ANGIOPOIETIN 2; CASPASE 3; CERULOPLASMIN; CYTOCHROME C; ENDOTHELIN 1; ENOLASE; ERYTHROPOIETIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUCOSE TRANSPORTER; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE ACETYLTRANSFERASE PCAF; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOGLYCERATE KINASE; PIMONIDAZOLE; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR; TYROSINE KINASE RECEPTOR; UNINDEXED DRUG; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; EMBRYO DEVELOPMENT; ENERGY METABOLISM; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HUMAN; HYPOXIA; IMMUNE RESPONSE; KELOID; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; STEM CELL; TISSUE OXYGENATION; TUMOR GROWTH; TUMOR INVASION; ANIMAL; ANOXIA; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); REVIEW;

ANIMALS; ANOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84884216334     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20123077     Document Type: Article

References (47)

1. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE. Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc Natl Acad Sci U S A 1991; 88: 5680-5684.
2. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12: 5447-5454.
3. Fong GH. Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis 2008; 11: 121-140.
4. Adams JM, Difazio LT, Rolandelli RH, Lujan JJ, Hasko G, Csoka B, et al. HIF-1: a key mediator in hypoxia. Acta Physiol Hung 2009; 96: 19-28.
5. Schumacker PT. Hypoxia-inducible factor-1 (HIF-1). Crit Care Med 2005; 33: S423-S425.
6. Semenza GL. Hypoxia-inducible factor 1 and cancer pathogenesis. Iubmb Life 2008; 60: 591-597.
7. Loor G, Schumacker PT. Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ 2008; 15: 686-690.
8. Kaelin WG. Proline hydroxylation and gene expression. Annu Rev Biochem 2005; 74: 115-128.
9. Arjumand W, Sultana S. Role of VHL gene mutation in human renal cell carcinoma. Tumour Biol 2012; 33: 9-16.
10. Kaelin WJ, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008; 30: 393-402.
11. Peet DJ, Lando D, Whelan DA, Whitelaw ML, Gorman JJ. Oxygen-dependent asparagine hydroxylation. Methods Enzymol 2004; 381: 467-487.
12. Fisher TS, Etages SD, Hayes L, Crimin K, Li B. Analysis of ARD1 function in hypoxia response using retroviral RNA interference. J Biol Chem 2005; 280: 17749-17757.
13. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006; 70: 1469-1480.
14. Niu G, Briggs J, Deng J, Ma Y, Lee H, Kortylewski M, et al. Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1 alpha RNA expression in both tumor cells and tumor-associated myeloid cells. Mol Cancer Res 2008; 6: 1099-1105.
15. Brahimi-Horn C, Pouyssegur J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull Cancer 2006; 93: E73-E80.
16. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp Mol Med 2004; 36: 1-12.
17. Mazure NM, Brahimi-Horn MC, Pouyssegur J. Protein kinases and the hypoxia-inducible factor-1, two switches in angiogenesis. Curr Pharm Des 2003; 9: 531-541.
18. Ahluwalia A, Tarnawski AS. Critical role of hypoxia sensor--HIF-1 alpha in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr Med Chem 2012; 19: 90-97.
19. Grenz A, Clambey E, Eltzschig HK. Hypoxia signaling during intestinal ischemia and inflammation. Curr Opin Crit Care 2012; 18: 178-185.
20. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, et al. HIF-1 alpha is essential for myeloid cell-mediated inflammation. Cell 2003; 112: 645-657.
21. Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, Covello KL, et al. The transcription factor HIF-1 alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev 2007; 21: 1037-1049.
22. Fraga A, Ribeiro R, Medeiros R. [Tumor hypoxia: the role of HIF]. Actas Urol Esp 2009; 33: 941-951.
23. Andrikopoulou E, Zhang X, Sebastian R, Marti G, Liu L, Milner SM, et al. Current Insights into the role of HIF-1 in cutaneous wound healing. Curr Mol Med 2011; 11: 218-235.
24. Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, Baek JH, et al. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 2006; 66: 2725-2731.
25. Keith B, Johnson RS, Simon MC. HIF-1 alpha and HIF-2 alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 2012; 12: 9-22.
26. Li Z, Rich JN. Hypoxia and hypoxia inducible factors in cancer stem cell maintenance. Curr Top Microbiol Immunol 2010; 345: 21-30.
27. Gonzalez IR, Moreno-Manzano V, Rodriguez-Jimenez FJ, Sepulveda P, Sanchez-Puelles JM. The biology of HIFalpha proteins in cell differentiation and disease. Vitam Horm 2011; 87: 367-379.
28. Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47.
29. Wu D, Zhu X, Zhang H. Effect of Silencing HIF-1α on Radiosensitization in Human Hepatocellular Carcinoma Cell Line. Chinese Journal of Clinical Oncology 2009; 36: 110-111.
30. Rohwer N, Cramer T. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resist Updat 2011; 14: 191-201.
31. Sendoel A, Kohler I, Fellmann C, Lowe SW, Hengartner MO. HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase. Nature 2010; 465: 577-583.
32. Mizokami K, Kakeji Y, Oda S, Maehara Y. Relationship of hypoxia-inducible factor 1 alpha and p21WAF1/CIP1 expression to cell apoptosis and clinical outcome in patients with gastric cancer. World J Surg Oncol 2006; 4: 94.
33. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 2001; 61: 6669-6673.
34. Greijer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004; 57: 1009-1014.
35. Zhang Q, Wu Y, Ann DK, Messadi DV, Tuan TL, Kelly AP, et al. Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol 2003; 121: 1005-1012.
36. Zhang Q, Oh CK, Messadi DV, Duong HS, Kelly AP, Soo C, et al. Hypoxia-induced HIF-1 alpha accumulation is augmented in a co-culture of keloid fibroblasts and human mast cells: involvement of ERK1/2 and PI-3K/Akt. Exp Cell Res 2006; 312: 145-155.
37. Vincent AS, Phan TT, Mukhopadhyay A, Lim HY, Halliwell B, Wong KP. Human skin keloid fibroblasts display bioenergetics of cancer cells. J Invest Dermatol 2008; 128: 702-709.
38. Genbacev O. To proliferate or to divide-to be or not to be. Early Pregnancy 2001; 5: 63-64.
39. Lee YM, Jeong CH, Koo SY, Son MJ, Song HS, Bae SK, et al. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev Dyn 2001; 220: 175-186.
40. Minet E, Michel G, Remacle J, Michiels C. Role of HIF-1 as a transcription factor involved in embryonic development, cancer progression and apoptosis (review). Int J Mol Med 2000; 5: 253-259.
41. Ramirez-Bergeron DL, Simon MC. Hypoxia-inducible factor and the development of stem cells of the cardiovascular system. Stem Cells 2001; 19: 279-286.
42. Cipolleschi MG, Dello SP, Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 1993; 82: 2031-2037.
43. Ivanovic Z, Dello SP, Trimoreau F, Faucher JL, Praloran V. Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percent. Transfusion 2000; 40: 1482-1488.
44. Ivanovic Z, Belloc F, Faucher JL, Cipolleschi MG, Praloran V, Dello SP. Hypoxia maintains and interleukin-3 reduces the pre-colony-forming cell potential of dividing CD34(+) murine bone marrow cells. Exp Hematol 2002; 30: 67-73.
45. Zhu LL, Wu LY, Yew DT, Fan M. Effects of hypoxia on the proliferation and differentiation of NSCs. Mol Neurobiol 2005; 31: 231-242.
46. Ceradini DJ, Gurtner GC. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 2005; 15: 57-63.
47. Maisel M, Habisch HJ, Royer L, Herr A, Milosevic J, Hermann A, et al. Genome-wide expression profiling and functional network analysis upon neuroectodermal conversion of human mesenchymal stem cells suggest HIF-1 and miR-124a as important regulators. Exp Cell Res 2010; 316: 2760-2778.